OpenEvidence: $250 Million Series D At $12 Billion Valuation Raised To Expand AI ‘Medical Superintelligence’ Platform for Doctors
By Amit Chowdhry ● Jan 21, 2026
OpenEvidence, an AI-powered medical search platform used by clinicians, said it has raised $250 million in a Series D financing that values the company at $12 billion, positioning it as the highest-valued healthcare AI company. Thrive Capital and DST Global co-led the financing. This round brings the total funding raised over the past 12 months to roughly $700 million. And it listed a broad roster of prior investors, including Sequoia, Google Ventures, Nvidia, Kleiner Perkins, Blackstone, Henry Kravis, Coatue, Thrive Capital, Conviction, ICONIQ, Greycroft, Breyer Capital, BOND, Craft Ventures, Goanna, Meritech, Alkeon, and Mayo Clinic, among others.